Jim Cramer warns Travere Therapeutics is losing a ton of money. He advises holding onto Palantir as a spec and expects good ...

Palantir Chairman Peter Thiel has completed ... or earlier. Executives and directors adopt such plans to remove the potential ...

Palantir stock has soared since it was announced ... or earlier. Executives and directors adopt such plans to remove the ...